Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$2.49B |
| 2 |
NVIDIA
NVDA
|
+$2.19B |
| 3 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.94B |
| 4 |
TSMC
TSM
|
+$728M |
| 5 |
UnitedHealth
UNH
|
+$705M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$775M |
| 2 |
AbbVie
ABBV
|
+$540M |
| 3 |
Delta Air Lines
DAL
|
+$434M |
| 4 |
Eli Lilly
LLY
|
+$433M |
| 5 |
DexCom
DXCM
|
+$433M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.89% |
| 2 | Healthcare | 2.92% |
| 3 | Financials | 2.71% |
| 4 | Consumer Discretionary | 2.52% |
| 5 | Industrials | 2.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11626
PUT
Cardiff Oncology
CRDF
$74.7M
| $96.9K | ﹤0.01% |
34,500
+15,900
| +85% | +$36.9K |
|
11627
CALL
Thryv Holdings
THRY
$109M
| $96.8K | ﹤0.01% |
+16,000
| New | +$127K |
|
11628
CALL
Heartland Express
HTLD
$952M
| $96.6K | ﹤0.01% |
10,700
-6,300
| -37% | -$52.4K |
|
11629
Fathom Holdings
FTHM
$24.8M
| $96.5K | ﹤0.01% |
95,519
+47,202
| +98% | +$63.6K |
|
|
SUIG
11630
PUT
Sui Group Holdings
SUIG
$72.8M
| $96.4K | ﹤0.01% |
57,700
+27,500
| +91% | +$71.1K |
|
|
PMNT
11631
DELISTED
PERFECT MOMENT LTD
PMNT
| $96.3K | ﹤0.01% |
231,485
+105,334
| +83% | +$49.3K |
|
|
ARDT
11632
CALL
Ardent Health
ARDT
$1.66B
| $96.2K | ﹤0.01% |
10,900
-6,100
| -36% | -$70.5K |
|
|
MAPS
11633
CALL
DELISTED
WM TECHNOLOGY INC A
MAPS
| $96K | ﹤0.01% |
116,400
+88,600
| +319% | +$87.2K |
|
|
UROY
11634
CALL
Uranium Royalty Corp
UROY
$1.51B
| $95.9K | ﹤0.01% |
+27,100
| New | +$106K |
|
|
FLD
11635
CALL
Fold Holdings
FLD
$25.2M
| $95.8K | ﹤0.01% |
36,700
-10,200
| -22% | -$33.8K |
|
|
TOKE
11636
PUT
DELISTED
Cambria Cannabis ETF
TOKE
| $95.5K | ﹤0.01% |
+15,500
| New | +$91.9K |
|
11637
CALL
InflaRx
IFRX
$253M
| $95.4K | ﹤0.01% |
94,500
+42,500
| +82% | +$52.8K |
|
11638
Cytosorbents Corp
CTSO
$25M
| $95.4K | ﹤0.01% |
149,279
+83,589
| +127% | +$64.3K |
|
|
STLN
11639
PUT
Starling Oncology Institute, Inc. Common Stock
STLN
$499M
| $95.4K | ﹤0.01% |
26,800
+12,400
| +86% | +$46K |
|
|
LND
11640
BrasilAgro
LND
$358M
| $95.2K | ﹤0.01% |
26,598
-36,896
| -58% | -$135K |
|
11641
KULR Technology Group
KULR
$128M
| $95.2K | ﹤0.01% |
32,158
-576,055
| -95% | -$2.11M |
|
|
STEX
11642
PUT
Streamex Corp
STEX
$75.3M
| $95.1K | ﹤0.01% |
31,400
+2,400
| +8% | +$10.7K |
|
11643
PUT
Offerpad Solutions
OPAD
$21.9M
| $95K | ﹤0.01% |
7,850
-16,610
| -68% | -$367K |
|
|
SGMO
11644
PUT
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $94.9K | ﹤0.01% |
225,900
-21,700
| -9% | -$11.5K |
|
|
BCYC
11645
PUT
Bicycle Therapeutics
BCYC
$278M
| $94.9K | ﹤0.01% |
+13,400
| New | +$98.8K |
|
|
CNSY
11646
Cerenome, Inc. Common Stock
CNSY
$26.6M
| $94.8K | ﹤0.01% |
+7,402
| New | +$112K |
|
11647
Alpha Pro Tech
APT
$53.3M
| $94.8K | ﹤0.01% |
21,351
-15,444
| -42% | -$71.1K |
|
11648
PUT
Culp Inc
CULP
$44.8M
| $94.7K | ﹤0.01% |
+26,600
| New | +$105K |
|
11649
PUT
Rimini Street
RMNI
$462M
| $94.7K | ﹤0.01% |
24,400
-4,100
| -14% | -$17K |
|
|
BTM
11650
CALL
DELISTED
Bitcoin Depot
BTM
| $94.6K | ﹤0.01% |
10,471
-22,443
| -68% | -$344K |
|
Similar funds
Citadel Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Citadel Advisors held 14,701 positions worth $666B, up 1.3% from $657B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q4 2025 filing shows 2,078 new, 5,000 increased, 5,362 reduced and 2,191 closed positions. Its largest new stake was Medline Inc: 6,006,339 shares worth $252M. The largest sale was Meta Platforms (Facebook), an estimated $775M.
By sector, the portfolio is most concentrated in Technology at 4.9% of assets, up from 3.8% a quarter earlier, followed by Healthcare and Financials.
- Citadel Advisors's largest Q4 2025 buy was Medline Inc: 6,006,339 shares worth $252M.
- Citadel Advisors added most to Amazon in Q4 2025, an estimated $2.49B increase.
- Citadel Advisors's biggest Q4 2025 reduction was Meta Platforms (Facebook), cutting an estimated $775M.
- Citadel Advisors fully exited WEX in Q4 2025, selling an estimated $131M.
- Citadel Advisors's ten largest holdings make up 23% of its $666B portfolio in Q4 2025.
- Citadel Advisors opened 2,078 new positions and closed 2,191 in Q4 2025.
- Citadel Advisors's portfolio value rose 1.3% quarter-over-quarter to $666B.
Based on Citadel Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.